boosh meaning

8,000 plus Attend Boosh Sponsored Planted Expo in Vancouver

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company") is proud to announce that over 8,000 consumers and investors visited the largest plant-based expo in Canada; Planted-Expo at which Boosh was the presenting sponsor. At the event Boosh proudly introduced its brand-new shelf stable line of Boosh Mac & Cheeze; Nacho and Better Cheddar to rave reviews, and provided samples to consumers of Boosh's favourite foods including Shephard's Pie, and recently acquired brands such as Salt Spring Harvest pate and Pulse Specialty Kitchen plant-based cheeses.

"We were ecstatic that literally thousands of people stopped by our booth and sampled our wonderful variety of plant-based cheeses, entrees and meals. We also added over 800 social media followers and sold thousands of dollars of products from our Booth. By the end of the event we had even sold out of the Mac & Cheeze lines," states Connie Marples founder and president of Boosh.

"This was an excellent opportunity to meet over one hundred local shareholders and investors in a casual setting, share stories and sample all types of Boosh products," states Jim Pakulis CEO of Boosh. "Just as importantly, management was also able to introduce Boosh to buyers in the food service industry such as the restaurant and bar sectors. In short, the event was a huge success for Team Boosh!"

In other news TJ Walsh, Boosh's newly hired VP of Sales North America, commenced work on Monday. TJ is responsible for all sales strategy, development, direction and budget. He will be developing on-site sales training and policy formulation, and will report directly to the president, Connie Marples, and CEO Jim Pakulis. TJ has extensive sales experience including, but not limited, to National Director of Sales for Silver Hills, a plant-based bakery and organic foods company. Prior to that, he was Sales Manager for UNFI, North America's largest all natural and organic distributor. Previously, he spent eight years with Bolthouse Farms, eventually being promoted to Director of Field Sales. At Bolthouse Farms, he was responsible for implementing a multi-million dollar sales budget, overseeing 30 sales representatives, developing strategic growth plans for selling all new product lines, and creating merchandising and sales strategies for Walmart, Kroger, Target, Safeway/Albertsons, HEB, Loblaws, Save On, Kroger's and Whole Foods.

The board of directors extended CEO Jim Pakulis' consulting agreement for one year of services. In exchange, the Company will provide Jim with 250,00 warrants priced at $2.00 and an exercise period of four years, and fifty thousand dollars.

"I'm committed to lead Boosh for the long run, however long that takes. Equally important, I'm committed to building our infrastructure, seek out key acquisitions and expand Boosh throughout North America. My personal belief is a two dollar exercise price for the warrants offered to me is fair and equitable based on where I believe the company is heading," states Jim Pakulis.

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (833) 882-6674

About Boosh Plant-Based Brands Inc.:

Boosh Plant-Based Brands Inc., through its wholly owned subsidiary, Boosh Food (, offers high quality, non-GMO, gluten free, 100% plant-based nutritional comfort foods for the whole family. We currently offer six frozen meals and three refrigerated meals which are sold throughout Canada. Boosh, good for you and good for planet earth.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward-looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the Company's proposed use of the proceeds of its initial public offering. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward-looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit

News Provided by Newsfile via QuoteMedia

The Conversation (0)
double helix molecule with ETFs stock chart

5 Small Biotech ETFs to Watch

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. Biotech ETFs allow market participants to gain leverage in multiple biotech companies via one investment vehicle.

The life science sector can certainly be risky, and ETFs are a good way to enter more safely than by investing in standalone stocks. A key advantage is that even if one company in the ETF takes a hit, the impact will be less direct.

Below the Investing News Network takes a look at five small biotech ETFs for investors to consider. They were selected using, and their total assets under management (AUM) were under US$100 million as of November 6, 2023. All other figures were also current as of that date.

Keep reading...Show less


Amgen (NASDAQ:AMGN) will present at the Evercore ISI HealthCONx Conference at 9:10 a.m. EST on Wednesday Nov. 29, 2023. Peter H. Griffith executive vice president and chief financial officer at Amgen, and Paul Burton senior vice president and chief medical officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less


New Repatha ® (evolocumab) Data Show No Decline in Cognitive Function Associated With Very Low Levels of LDL-C

Olpasiran Research Provides Further Insights Into Cardiovascular Risks Associated With Elevated Lp(a)

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Hydralyte International (ASX:HPC)

Hydralyte International

Keep reading...Show less


FOREMOST Study Finds Oral Otezla ® (apremilast) Significantly Improved Disease Control vs. Placebo

Amgen (NASDAQ:AMGN) today announced results from the global Phase 4 FOREMOST study evaluating Otezla ® (apremilast) in patients with early oligoarticular psoriatic arthritis. FOREMOST is the first placebo-controlled study designed to specifically assess people with oligoarticular psoriatic arthritis with early disease duration of five or fewer years. Results will be presented at the American College of Rheumatology (ACR) Convergence 2023, Nov. 10-15 in San Diego .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News